Prognostic Significance of Preoperative Albumin-Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma

• Bo Zhang ,

  Contributed equally to this work with: Bo Zhang, Wei Yu

  Affiliations Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China, Institute of Urology, Peking University, Beijing, People’s Republic of China, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Wei Yu ,

  Contributed equally to this work with: Bo Zhang, Wei Yu

  Affiliations Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China, Institute of Urology, Peking University, Beijing, People’s Republic of China, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Li-Qun Zhou,

  Affiliations Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China, Institute of Urology, Peking University, Beijing, People’s Republic of China, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Zhi-Song He,

  Affiliations Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China, Institute of Urology, Peking University, Beijing, People’s Republic of China, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Cheng Shen,

  Affiliations Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China, Institute of Urology, Peking University, Beijing, People’s Republic of China, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Qun He,

  Affiliations Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China, Institute of Urology, Peking University, Beijing, People’s Republic of China, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Jun Li,

  Affiliations Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China, Institute of Urology, Peking University, Beijing, People’s Republic of China, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Li-Bo Liu,

  Affiliations Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China, Institute of Urology, Peking University, Beijing, People’s Republic of China, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Cong Wang,

  Affiliation Peking University Health Science Center, Beijing, People’s Republic of China

  ⨯
• Xiao-Yu Chen,

  Affiliation Peking University Health Science Center, Beijing, People’s Republic of China

  ⨯
• Yu Fan,

  Affiliations Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China, Institute of Urology, Peking University, Beijing, People’s Republic of China, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Shuai Hu,

  Affiliations Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China, Institute of Urology, Peking University, Beijing, People’s Republic of China, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Lei Zhang,

  Affiliations Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China, Institute of Urology, Peking University, Beijing, People’s Republic of China, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Wen-Ke Han ,

  * E-mail: hanwenke@medmail.com.cn (WKH); jinjie@vip.163.com (JJ)

  Affiliations Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China, Institute of Urology, Peking University, Beijing, People’s Republic of China, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Jie Jin

  * E-mail: hanwenke@medmail.com.cn (WKH); jinjie@vip.163.com (JJ)

  Affiliations Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China, Institute of Urology, Peking University, Beijing, People’s Republic of China, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯